What is the starting dose of nortriptyline (tricyclic antidepressant)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Dose of Nortriptyline

The recommended starting dose of nortriptyline is 10 mg at bedtime for elderly patients and 25 mg three to four times daily (or as a single bedtime dose) for younger adults, with the FDA label specifying that dosage should begin at a low level and be increased gradually as required. 1, 2

Standard Adult Dosing

  • For general adult patients, the FDA-approved starting regimen is 25 mg given 3 or 4 times daily, though the total daily dose may alternatively be given once daily at bedtime 2
  • The initial dose should be started low and titrated upward based on clinical response and tolerability, checking carefully for evidence of intolerance 2
  • As an alternative approach for outpatients, starting with 25 mg at bedtime and titrating upward is common in clinical practice 3

Elderly and Frail Patients

  • For elderly patients, the starting dose should be 10 mg at bedtime, which is significantly lower than the standard adult dose due to increased sensitivity to side effects 1, 4
  • The FDA label specifically recommends 30 to 50 mg/day in divided doses for elderly patients as the usual maintenance range, but initiation should start lower 2
  • Guidelines emphasize starting at 10 mg/day in older patients to minimize anticholinergic effects, cardiotoxicity, and orthostatic hypotension 1

Titration Strategy

  • Increase the dose gradually using increments of the initial dose every 5 to 7 days until therapeutic benefits or significant side effects become apparent 1
  • The therapeutic target plasma level "window" is 50 to 150 ng/mL (190 to 570 nmol per L), which helps guide dose adjustments 1
  • When doses above 100 mg daily are administered, plasma levels should be monitored and maintained in the optimum range of 50 to 150 ng/mL 2

Maximum Dosing and Safety Limits

  • Doses above 150 mg per day are not recommended per FDA labeling 2
  • Doses greater than 100 mg/day are associated with increased risk of sudden cardiac death, particularly in patients with cardiovascular disease, requiring extreme caution 1, 4
  • A baseline ECG is essential before initiating treatment; if the PR or QTc interval is prolonged, nortriptyline should not be used 1, 4

Clinical Considerations

  • Nortriptyline tends to be more sedating than other tricyclics like desipramine, making it useful for patients with agitated depression and insomnia when dosed at bedtime 1
  • It has fewer anticholinergic effects compared to amitriptyline, making it the preferred tricyclic for elderly patients 4
  • A full therapeutic trial requires at least 4 to 8 weeks to assess efficacy 1
  • Common side effects include dry mouth, constipation, blurred vision, somnolence, and potential cardiac effects such as QTc prolongation 4

Special Populations

  • For smoking cessation trials, nortriptyline was started at 25 mg before bed 10 days prior to quit day and titrated to 75 mg/day or the maximal tolerated dose 3
  • In frail elderly patients (average age 84), the average dose required to achieve a plasma level of 100 ng/mL is approximately 80 mg/day, though individual requirements vary by a factor of 20 5
  • A 25-mg test dose can be used in elderly patients to predict steady-state levels and individualize dosing, avoiding the higher 50-mg test dose that may cause unmanageable acute side effects 6, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A randomized trial of nortriptyline for smoking cessation.

Archives of internal medicine, 1998

Guideline

Nortriptyline Side Effects and Clinical Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Steady state pharmacokinetics of nortriptyline in the frail elderly.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.